Clinical parameter | Value |
Age at diagnosis, years, median (IQR) | 64 (56–73) |
Females, n (%) | 7 (25) |
BMI, kg/m2 (IQR) | 20.9 (19.3–23.0) |
History | |
Allergy, n (%) | 11 (39) |
Asthma, n (%) | 3 (11) |
Organ involvement, n (%) | |
Lacrimal gland and orbit | 10 (36) |
Salivary gland | 15 (54) |
Lymph node | 18 (64) |
Thyroid | 2 (7) |
Lung | 5 (18) |
Pancreas | 4 (14) |
Bile duct | 1 (4) |
Kidney | 4 (14) |
Aorta | 4 (14) |
Prostate | 2 (7) |
Retroperitoneum | 5 (18) |
No of affected organs, median (IQR) | 2 (1–3) |
IgG4-RD Responder Index, median (IQR) | 9 (6–15) |
Laboratory test results, median (IQR) | |
White cells, ×109/μL | 6.4 (5.4–7.4) |
Eosinophils, % | 5.0 (2.0–6.4) |
Haemoglobin, g/dL | 13.1 (12.1–14.5) |
Platelets, ×109/μL | 230 (195–260) |
C-reactive protein, mg/dL | 0.19 (0.05–0.77) |
Erythrocyte sedimentation rate, mm/hour | 41 (10–63) |
Creatinine, mg/dL | 0.83 (0.61–0.95) |
Estimated GFR, mL/min/1.73 m2 | 71.9 (60.2–81.0) |
Soluble IL-2 receptor, U/mL | 584 (454–1261) |
IgG, mg/dL | 1985 (1494–3039) |
IgG4, mg/dL | 393 (175–876) |
IgG4/IgG ratio, % | 18.3 (11.1–34.0) |
IgE, IU/mL | 632 (203–1435) |
BMI, body mass index; GFR, glomerular filtration rate; IgG4-RD: IgG4-related disease; IL-2, interleukin-2.